MX2023007810A - Compuestos de complejo de hierro para uso terapeutico. - Google Patents

Compuestos de complejo de hierro para uso terapeutico.

Info

Publication number
MX2023007810A
MX2023007810A MX2023007810A MX2023007810A MX2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A
Authority
MX
Mexico
Prior art keywords
complex compounds
iron complex
therapeutic use
iron
arsenic
Prior art date
Application number
MX2023007810A
Other languages
English (en)
Inventor
Tobias S Christensen
Hans B Andreasen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of MX2023007810A publication Critical patent/MX2023007810A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a compuestos de complejo de hierro para uso terapéutico que son bajos en arsénico, cromo, plomo, cadmio, mercurio y/o aluminio, a composiciones de los mismos y a procesos de preparación de dichos compuestos de complejo de hierro.
MX2023007810A 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico. MX2023007810A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17190302 2017-09-11

Publications (1)

Publication Number Publication Date
MX2023007810A true MX2023007810A (es) 2023-07-11

Family

ID=59923237

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2020002527A MX2020002527A (es) 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico.
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.
MX2023007810A MX2023007810A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2020002527A MX2020002527A (es) 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico.
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Country Status (12)

Country Link
US (2) US11111261B2 (es)
EP (1) EP3681539A1 (es)
JP (2) JP7426927B2 (es)
KR (1) KR20200044030A (es)
CN (1) CN111050802A (es)
AU (2) AU2018328052B2 (es)
BR (1) BR112020004357A2 (es)
MA (1) MA50229A (es)
MX (3) MX2020002527A (es)
SG (1) SG11202001594TA (es)
WO (1) WO2019048674A1 (es)
ZA (1) ZA202001283B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200044030A (ko) * 2017-09-11 2020-04-28 파르마코스모스 홀딩 에이/에스 치료용 철 착화합물
US20220062331A1 (en) 2019-01-10 2022-03-03 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
CN114286682A (zh) 2019-02-09 2022-04-05 法码科思莫斯控股有限公司 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁
SI3930686T1 (sl) 2019-02-28 2023-11-30 Renibus Therapeutics, Inc. Novi železovi sestavki ter metode njihove izdelave in uporabe
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
CN114376981B (zh) * 2022-01-13 2023-10-20 上海医药集团青岛国风药业股份有限公司 一种多糖铁复合物胶囊的制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR607134A (fr) 1924-12-03 1926-06-26 Basf Ag Procédé pour la production du fer carbonyle
FR654013A (fr) * 1928-05-09 1929-03-30 Procédé de réglage de la carburation dans les moteurs à explosions et dispositifen permettant la réalisation
US2096855A (en) * 1934-07-27 1937-10-26 Innis Speiden & Co Manufacture of ferric chloride
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US3906077A (en) 1974-02-15 1975-09-16 Kerr Mc Gee Chem Corp Purification of ferric chloride
US4056386A (en) 1977-04-19 1977-11-01 The United States Of America As Represented By The Secretary Of The Navy Method for decomposing iron pentacarbonyl
CA2318823A1 (en) 1998-02-25 1999-09-02 Satish C. Wadhawan Solvent extraction of ferric chloride
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
GB0702270D0 (en) * 2007-02-06 2007-03-14 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
CA2756580A1 (en) * 2009-03-25 2010-09-30 Hans Andreasen A stable iron oligosaccharide compound
CN102065406B (zh) 2009-11-12 2014-04-09 中兴通讯股份有限公司 一种本地呼叫本地交换的实现方法
US11040059B2 (en) 2014-10-27 2021-06-22 Pharmacosmos Holding A/S Treatment or prevention of anaemia in pregnant non-human mammals
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)
WO2016181195A1 (en) * 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
BR112017028025B1 (pt) 2015-06-22 2023-04-18 Pharmacosmos Holding A/S Usos de um complexo de ferro-carboidrato para o tratamento ou prevenção de uma deficiência de ferro de um feto ou de um bebê
CN105095365A (zh) 2015-06-26 2015-11-25 北京奇虎科技有限公司 一种信息流数据的处理方法和装置
RU2720512C1 (ru) * 2016-05-20 2020-04-30 Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" Готовая к применению инъекционная композиция для профилактики и лечения железодефицитной анемии
KR20200044030A (ko) * 2017-09-11 2020-04-28 파르마코스모스 홀딩 에이/에스 치료용 철 착화합물

Also Published As

Publication number Publication date
US11111261B2 (en) 2021-09-07
EP3681539A1 (en) 2020-07-22
MX2023007809A (es) 2023-07-11
MA50229A (fr) 2020-07-22
JP7426927B2 (ja) 2024-02-02
RU2020113257A3 (es) 2022-04-25
KR20200044030A (ko) 2020-04-28
US20190177353A1 (en) 2019-06-13
AU2018328052B2 (en) 2024-02-29
JP2023164477A (ja) 2023-11-10
RU2020113257A (ru) 2021-10-13
US20220041640A1 (en) 2022-02-10
MX2020002527A (es) 2020-10-12
JP2020533300A (ja) 2020-11-19
AU2018328052A1 (en) 2020-03-26
CN111050802A (zh) 2020-04-21
AU2024203596A1 (en) 2024-06-20
ZA202001283B (en) 2022-11-30
SG11202001594TA (en) 2020-03-30
BR112020004357A2 (pt) 2020-09-08
WO2019048674A1 (en) 2019-03-14

Similar Documents

Publication Publication Date Title
MX2023007810A (es) Compuestos de complejo de hierro para uso terapeutico.
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
MX2023010042A (es) Polinucleotidos moduladores.
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
ZA201906832B (en) Novel psma-binding agents and uses thereof
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MA44322A (fr) Compositions comprenant des souches bactériennes
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
PH12016501763A1 (en) Multispecific antibodies
MX2019007021A (es) Anticuerpos il-11ra.
MA42471A (fr) Compositions comprenant des souches bactériennes
NZ738008A (en) Tigit-binding agents and uses thereof
MX2017015908A (es) Anticuerpos de union a tau.
MX2019011496A (es) Composiciones de niraparib.
MY196308A (en) PTH Prodrugs
PH12017502207A1 (en) Tau-binding antibodies
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
GB2568181A (en) Wheat
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2019003755A (es) Regimen de dosificacion de avelumab para el tratamiento de cancer.
MX2017010526A (es) Mezclas de aceite, procesos para la preparacion de estas y su uso en formulas.